RU2001104349A - Композиции и способы для терапии и диагностики рака предстательной железы - Google Patents

Композиции и способы для терапии и диагностики рака предстательной железы

Info

Publication number
RU2001104349A
RU2001104349A RU2001104349/14A RU2001104349A RU2001104349A RU 2001104349 A RU2001104349 A RU 2001104349A RU 2001104349/14 A RU2001104349/14 A RU 2001104349/14A RU 2001104349 A RU2001104349 A RU 2001104349A RU 2001104349 A RU2001104349 A RU 2001104349A
Authority
RU
Russia
Prior art keywords
diagnostics
therapy
compositions
methods
prostate cancer
Prior art date
Application number
RU2001104349/14A
Other languages
English (en)
Other versions
RU2234942C2 (ru
Inventor
Дэвин Клиффорд ДИЛЛОН
Сюзан Луиз ХАРЛОКЕР
Дзианг ЮКВИУ
Дзиангчун КСУ
Дженнифер Линн МИТЧАМ
Original Assignee
Корикса Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/115,453 external-priority patent/US6657056B2/en
Priority claimed from US09/232,149 external-priority patent/US6465611B1/en
Application filed by Корикса Корпорейшн filed Critical Корикса Корпорейшн
Publication of RU2001104349A publication Critical patent/RU2001104349A/ru
Application granted granted Critical
Publication of RU2234942C2 publication Critical patent/RU2234942C2/ru

Links

Claims (2)

1. Выделенный полинуклеотид, содержащий последовательность SEQ ID NO: 225 или SEQ ID NO: 326.
2. Выделенный полипептид, содержащий последовательность SEQ ID NO: 327.
RU2001104349/15A 1998-07-14 1999-07-14 Выделенный опухолевый полипептид предстательной железы и кодирующий его полинуклеотид RU2234942C2 (ru)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US09/115,453 US6657056B2 (en) 1997-02-25 1998-07-14 Compounds for immunotherapy of prostate cancer and methods for their use
US09/116,134 1998-07-14
US09/115,453 1998-07-14
US09/159,812 1998-09-23
US09/159,822 1998-09-23
US09/232,880 1999-01-15
US09/232,149 US6465611B1 (en) 1997-02-25 1999-01-15 Compounds for immunotherapy of prostate cancer and methods for their use
US09/232,149 1999-01-15
US09/288,946 1999-04-09

Publications (2)

Publication Number Publication Date
RU2001104349A true RU2001104349A (ru) 2003-02-20
RU2234942C2 RU2234942C2 (ru) 2004-08-27

Family

ID=33422454

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001104349/15A RU2234942C2 (ru) 1998-07-14 1999-07-14 Выделенный опухолевый полипептид предстательной железы и кодирующий его полинуклеотид

Country Status (1)

Country Link
RU (1) RU2234942C2 (ru)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0625321D0 (en) * 2006-12-19 2007-01-24 Univ Surrey Cancer biomarker
CN101663323A (zh) * 2006-12-27 2010-03-03 埃默里大学 用于治疗传染病和肿瘤的组合物和方法
WO2009046739A1 (en) * 2007-10-09 2009-04-16 Curevac Gmbh Composition for treating prostate cancer (pca)
HUE027332T2 (en) * 2008-08-05 2016-09-28 Toray Industries Cancer Detection Method
PL2322221T3 (pl) 2008-08-05 2015-01-30 Toray Industries Kompozycja farmaceutyczna do leczenia i zapobiegania raka
PT2532743E (pt) 2010-02-04 2015-08-04 Toray Industries Composição farmacêutica para o tratamento e/ou a prevenção de cancro
PL2532366T3 (pl) 2010-02-04 2017-02-28 Toray Industries, Inc. Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi
ES2583627T3 (es) 2010-02-04 2016-09-21 Toray Industries, Inc. Composición farmacéutica para el tratamiento y/o la prevención del cáncer
ES2583777T3 (es) 2010-02-04 2016-09-22 Toray Industries, Inc. Composición farmacéutica que comprende anticuerpos anti CAPRIN-1 para el tratamiento y/o la prevención del cáncer
US9180187B2 (en) 2010-02-04 2015-11-10 Toray Industries, Inc. Medicament for treating and/or preventing cancer
TR201808595T4 (tr) 2011-08-04 2018-07-23 Toray Industries Kanser hastalıklarının tedavisi ve/veya profilaksisi için farmasötik bileşim.
TR201802089T4 (tr) 2011-08-04 2018-03-21 Toray Industries Kanserin tedavisi ve/veya önlenmesi amacına yönelik ilaç bileşimi.
AU2012290949B2 (en) 2011-08-04 2017-03-02 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
RU2624040C2 (ru) 2011-08-04 2017-06-30 Торэй Индастриз, Инк. Способ обнаружения рака поджелудочной железы
ES2763122T3 (es) 2011-08-04 2020-05-27 Toray Industries Composición farmacéutica, que comprende anticuerpos contra caprin 1 para el tratamiento y/o para la prevención del cáncer
KR101980554B1 (ko) 2011-08-04 2019-05-21 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
RU2631804C2 (ru) 2012-02-21 2017-09-26 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения или профилактики рака
PL2818481T3 (pl) 2012-02-21 2020-02-28 Toray Industries, Inc. Kompozycja farmaceutyczna do leczenia i/lub zapobiegania nowotworowi złośliwemu
PT2824114T (pt) 2012-02-21 2019-08-05 Toray Industries Composição farmacêutica para o tratamento do cancro
CA2864864C (en) 2012-02-21 2020-05-12 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
PL2832366T3 (pl) 2012-03-30 2018-04-30 Toray Industries, Inc. Kompozycja farmaceutyczna do leczenia i/lub zapobiegania rakowi pęcherzyka żółciowego
ES2656620T3 (es) 2012-03-30 2018-02-27 Toray Industries, Inc. Composición farmacéutica para el tratamiento y/o la prevención del cáncer de hígado
PL2876447T3 (pl) 2012-07-19 2020-05-18 Toray Industries, Inc. Sposób wykrywania nowotworu
PL2876446T3 (pl) 2012-07-19 2019-06-28 Toray Industries, Inc. Sposób wykrywania nowotworu
US9862774B2 (en) 2013-08-09 2018-01-09 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer

Similar Documents

Publication Publication Date Title
RU2001104349A (ru) Композиции и способы для терапии и диагностики рака предстательной железы
EP2022800A3 (en) Compositions for the therapy and diagnosis of ovarian cancer
CA2376596A1 (en) Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
PT1187632E (pt) Tratamento com anticorpos anti-erbb2
DE69830072D1 (de) Radioaktive zusammensetzungen zur behandlung von prostatatumoren
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
NZ512247A (en) Compositions and methods for therapy and diagnosis of ovarian cancer
ZA993364B (en) Novel 4-phenylpiperidines for the treatment of pruritic dermatoses.
PL336470A1 (en) Mammalian cytokin-like factor 7
WO2000018439A3 (de) Verwendung von neoangiogenese-markern für diagnose und therapie von tumoren
WO1994005791A3 (en) Dorsal tissue affecting factor and compositions
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
WO1999067384A3 (en) Prostate cancer-associated genes
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
PT939809E (pt) Ligandos do receptor de tie-2 (ligando 3 de tie e ligando 4 de tie) e suas utilizacoes
CA2294566A1 (en) Ikk-.alpha. proteins, nucleic acids and methods
WO1999002704A3 (en) Dual specifically phosphatase and methods of use
WO2004029287A3 (en) Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
MXPA02000680A (es) Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf.
MXPA03000979A (es) Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas.
IL139604A0 (en) Novel peptides
ES2020953B3 (es) Complejos de tetrahidro-3,4-furanodiamina-n-n'platino.
WO1999031128A3 (en) Human tumor necrosis factor-r2-like proteins